logo
  Join        Login             Stock Quote

Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year

Thursday, March 29, 2012 1:18 PM


Physicians in SEMI submitting more than 1 million prescriptions per month electronically

DETROIT, March 29, 2012 /PRNewswire/ -- Six years ago, before smartphones were a veritable cornerstone of daily life, a few hundred physicians in Southeast Michigan joined an initiative to begin using similar handheld devices in an effort to more safely and efficiently prescribe medications for their patients. 

Today, the Steering Committee of the Southeast Michigan ePrescribing Initiative (SEMI) reports that more than 7,500 physicians in the area are actively prescribing in the program – a 33 percent increase from a year ago – and have submitted more than 40 million electronic prescriptions since the program began in 2005.  Due to this success, SEMI will continue supporting physicians in the practice of ePrescribing for a seventh consecutive year to ensure optimal use of ePrescribing and to maximize the quality and safety benefits as well as the cost savings they provide.

"In 2005, this diverse group of stakeholders came together for the common goal of improving the safety and efficiency of prescribing for physicians and patients.  We created SEMI to help advance the implementation of clinical technology in the physician office setting starting with ePrescribing, and each year, we are encouraged and excited to see that the program is making a profound and positive impact on our health care system," said Marsha Manning, Manager, Health Care Plans, General Motors.  "While we are making great strides, we still have more work to do to insure that ePrescribing is optimized.  We look forward to harnessing the momentum we have with SEMI to achieve this important goal."

SEMI was launched in 2005 to promote ePrescribing among physicians in Southeast Michigan. The coalition includes: General Motors, Ford Motor Company, Chrysler Group LLC, the  UAW Retiree Medical Benefits Trust, Blue Cross Blue Shield of Michigan, Health Alliance Plan, Henry Ford Medical Group, Medco Health Solutions, Inc., CVS Caremark Corporation and Catalyst Rx.

SEMI provides doctors with training and a support system to help integrate ePrescribing into their practice – two obstacles routinely cited by doctors who choose paper prescriptions over electronic prescriptions.

"SEMI's growth and success over the past six years is a testament to the design of the program, which balances support and training with a physician's own investment in the technology.  This formula is working, and is a win for patients, physicians and payors," said John Driscoll, President, New Markets at Medco and Co-Chair of the Board of Directors at SureScripts. "With the requirements and incentives to use electronic prescribing in the Medicare Part D legislation and the Patient Protection and Affordable Care Act, doctors need programs like SEMI more than ever to help them make ePrescribing the standard of care."

Since July 2011 electronic prescription volume among physicians in SEMI routinely surpasses 1 million each month.  An analysis conducted in December 2011 on a sample of 23 million prescriptions written by SEMI physicians since the program began also found:

  • A severe or moderate drug-to-drug alert was sent to physicians for more than 6.2  million prescriptions, resulting in 1.8 million (or 28 percent) of those prescriptions being changed or canceled by the prescribing doctor;
  • Physicians received nearly 923,000 medication allergy alerts, resulting in more than 250,000 (or 27 percent) of those prescriptions being changed or canceled by the prescribing doctor;
  • 8.2  million lists of dispensed prescription histories were downloaded by physicians; and
  • When a formulary alert was presented, physicians changed the prescription to comply with formulary requirements 28 percent of the time.

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.